Search clinical trials for: ENGERIX-B Hepatitis B Vaccine

Total 7018 results

VBI Vaccines Inc.

Completed

A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults

Hepatitis B

Vietnam
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Persistent Innate Immune Activation on Vaccine Efficacy

Hepatitis C Infection

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

Hepatitis B

Denmark, Belgium
Baylor College of Medicine
George Washington University; Makerere University Walter Reed Project

Active, not recruiting

Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

Schistosomiasis | Schistosoma Mansoni

Uganda
GlaxoSmithKline

Completed

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

Hepatitis B
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

Hepatitis B
University of North Carolina, Chapel Hill
Burroughs Wellcome; The American Society of Tropical Medicine and Hygiene

Completed

Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

Hepatitis B

Congo, The Democratic Republic of the
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Infections, Papillomavirus

Netherlands, Sweden
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

Hepatitis B

Australia, Czech Republic, Germany, Italy, Netherlands, Switzerland, United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Recruiting

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

RSV Immunization

United States, Puerto Rico
Duke University
Columbia University; Centers for Disease Control and Prevention; Children's Hospital... and other collaborators

Recruiting

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

Fever | Fever After Vaccination | Seizures Fever

United States
GlaxoSmithKline

Completed

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

Hepatitis B
GlaxoSmithKline

Completed

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

Hepatitis B

Thailand
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

HIV Infections

United States
National Institute for Public Health and the Environment...

Terminated

Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination (TANGO)

Human Papillomavirus Infection
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

Healthy

France
University of Maryland, Baltimore

Withdrawn

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B (BOOST-9)

Hepatitis B

United States
Shandong Province Centers for Disease Control and...
Centers for Disease Control and Prevention, China; National Institutes for...

Completed

Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China

Hepatitis B Vaccines
The University of Hong Kong

Completed

Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

Hepatitis B | Inflammatory Bowel Diseases

China
GlaxoSmithKline

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Hepatitis B | Hepatitis A

Australia
Dynavax Technologies Corporation

Completed

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Hepatitis B

United States
Shanxi Medical University

Not yet recruiting

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Hepatitis B Vaccine
Merck Sharp & Dohme LLC

Completed

Hepatitis B Challenge Dose in Adults (V232-059-10)

Hepatitis B
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age

Hepatitis B
Quaid-e-Azam University
Health Services Academy, Islamabad, Pakistan; Medical Research Council, Pakistan

Completed

Hepatitis B Birth Dose for Newborns (HepB-BirD)

Hepatitis B | Immunization; Infection

Pakistan
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

Virus Diseases | Hepatitis B

Italy
Novartis Vaccines

Completed

A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

Meningococcal Disease

United States, Australia, Canada
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Argentina
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico (MET33)

Healthy Volunteers (Meningococcal Infection)

Mexico, Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

HIV Infections

United States
Merck Sharp & Dohme LLC

Completed

Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)

Vaccine Response Impaired
University of Wisconsin, Madison

Completed

HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

Healthcare Worker, Hepatitis B Vaccine, Nonresponder

United States
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

HIV Infections | Hepatitis B

United States
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Hepatitis B

Germany, United Kingdom, Belgium
National Cancer Institute (NCI)

Terminated

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Breast Cancer | Bladder Cancer | Colon Cancer

United States
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine

China
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

Hepatitis B

Belgium
Merck Sharp & Dohme LLC

Completed

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

Hepatitis B

Finland
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
Chiang Mai University

Completed

Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts

Hepatitis B

Thailand
King Chulalongkorn Memorial Hospital
McGill University

Completed

Prognostic Factors in Malignant GI Bleeding Treated With Hemostatic Powder

Death

Thailand
Erasmus Medical Center
Stichting Nuts Ohra

Completed

Hepatitis B Vaccination in HIV-infected Persons

HIV Infections | Hepatitis B

Netherlands
IDEWE Occupational Health Services
GlaxoSmithKline

Unknown

Twinrix Alternative Schedule Study

Antibody Response After Vaccination

Belgium
National Institute of Allergy and Infectious Diseases...
Protein Sciences Corporation

Completed

A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

HIV Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia

China
Boston Medical Center

Completed

Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

Inflammatory Bowel Diseases

United States

3

Subscribe